Insulin-like growth factors and inflammatory bowel disease

Bailliere's Clinical Gastroenterology

Volumn 10, Issue 1, 1996, Pages 83-96

  Lund, P Kay ^a   Zimmermann, Ellen M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXTRAN SULFATE; GROWTH FACTOR; HORMONE; MESSENGER RNA; RECOMBINANT GROWTH HORMONE; RECOMBINANT PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; BURN; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CLINICAL TRIAL; CROHN DISEASE; ENTERITIS; FIBROSIS; GROWTH DISORDER; HUMAN; HYPERPLASIA; INTESTINE MUCOSA; LONG TERM CARE; MACROPHAGE; MESENCHYME CELL; MOUSE; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; RAT; REVIEW; RISK BENEFIT ANALYSIS; TRANSGENIC MOUSE; ULCERATIVE COLITIS; WOUND HEALING;

EID: 0029928613     PISSN: 09503528     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3528(96)90041-X     Document Type: Article

References (77)

1. Albiston AL, Taylor RG, Herington AC et al (1992) Divergent ileal IGF-I and IGFBP3 gene expression after small bowel resection: a novel mechanism to amplify IGF action. Molecular and Cell Endocrinology 83: R17-R20.
2. Bar RS, Boes M, Clemmons DR et al (1990a) Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2, and endothelial cell IGF-binding proteins in the rat heart. Endocrinology 127: 497-499.
3. Bar RS, Boes M, Dake BL et al (1990b) Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I. Endocrinology 127: 3243-3244.
4. Behringer R, Lewin T, Quaife C et al (1990) Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice. Endocrinology 127: 1033-1040.
5. Bondy CA, Underwood LE, Clemmons DR et al (1994) Clinical uses of insulin-like growth factor I. Annals of Internal Medicine 120: 593-601.
6. Carlsson-Skwirut C, Jornvail H, Holmgren A et al (1986) Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Letters 201: '46-50.
7. Clemmons DR & Van Wyk JJ (1985) Evidence for a functional role of endogenously produced somatomedin-like peptides in regulation of DNA synthesis in cultured human fibroblasts and paracrine smooth muscle cells. Journal of Clinical Investigation 75: 1914-1918.
8. Clemmons DR & Shaw DS (1986) Purification and biological properties of fibroblast somatomedin. Journal of Biological Chemistry 261: 10 293-10 298.
9. Clemmons DR & Underwood LE (1994) Clinical review 59: uses of human insulin-like growth factors in clinical conditions. Journal of Clinical and Endocrinological Metabolism 79: 4-6.
10. Clemmons DR, Thrailkill KM, Handwerger S & Busby WH (1990a) Three distinct forms of insulin-like growth factor binding proteins are released from decidual cells in culture. Endocrinology 127: 643-645.
11. Clemmons DR, Cascieri MA, Camacho-Hubner C et al (1990b) Discrete alterations of the insulin-like growth factor I molecule which after its affinity for insulin-like growth factor binding proteins result in changes in bioactivity. Journal of Biological Chemistry 265: 12 210-12 216.
12. Cohen JA, Zimmermann EM, Sartor RB & Lund PK (1993) IGF-I and IGF-II are overexpressed in inflamed and strictured intestine in Crohn's Disease. Gastroenterology 104(4): A683 (abstract).
13. Cooper HS, Murthy SNS, Shah RS & Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory Investigation 69(2): 238-245.
14. Czech MP (1989) Signal transmission by the insulin-like growth factors. Cell 59: 235-238.
15. D'Ercole A, Stiles A & Underwood L (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis, and paracrine or autocrine mechanisms of action. Proceedings of the National Academy of Sciences of the USA 81: 935-939.
16. Desmouliere A, Rubbia-Brandt L, Grau G & Gabbiani G (1992a) Heparin induces α-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Laboratory Investigation 67(6): 716-732.
17. Desmouliere A, Rubbia-Brandt L, Abdiu A et al (1992b) α-Smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by γ-interferon. Experimental Cell Research 201: 64-73.
18. Edwards CK, Lorence RM, Dunham DM et al (1991) Hypophysectomy inhibits the synthesis of tumor necrosis factor a by rat macrophages: partial restoration by exogenous growth hormone or interferon. Endocrinology 128: 989-996.
19. Fiocchi C (1992) In MacDermott RP & Stenson WF (eds) Inflammatory Bowel Disease, pp 137-162. New York: Elsevier Press.
20. Fu YK, Arkins S, Wnag BS & Kelley KW (1991) A novel role of growth hormone and insulin-like growth factor I priming neutrophils for superoxide anion secretion. Journal of Immunology 146: 1602-1608.
21. Gjerset RA, Yeargin J, Volkman SK et al (1990) Insulin-like growth factor-I supports proliferation of autocrine thymic lymphoma cells with a pre-T cell phenotype. Journal of Immunology 145: 3497-3501.
22. Graham MF (1992) Stricture formation: pathophysiologic and therapeutic concepts. In MacDermott RP & Seerson WF (eds) Inflammatory Bowel Disease, pp 323-336. New York: Elsevier Press.
23. Graham MF, Drucker DEM, Diegelmann RF & Elson CO (1987) Collagen synthesis by human intestinal smooth muscle cells in culture. Gastroenterology 92: 400-405.
24. Graham MF, Gluck UM & Shah BV (1994) β-Tropomyosin and α-actin are phenotypic markers for human intestinal smooth muscle cells in vitro. Molecular and Cellular Differentiation 2: 45-60.
25. Han VKM, D'Ercole AL & Lund PK (1987a) Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193-197.
26. Han VK, Hill DJ, Strain AJ et al (1987b) Identification of somatomedin/insulin-like growth factor immunoreactive cells in the human fetus. Pediatric Research 22: 245-249.
27. Hoyt EC, Van Wyk JJ & Lund PK (1988) Tissue and development specific regulation of a complex family of rat IGF-I mRNAs. Molecular Endocrinology 2: 1077-1086.
28. Jennische E, Skottner A & Hansson HA (1987) Dynamic changes in insulin-like growth factor I immunoreactivity correlate to repair events in rat ear after freeze-thaw injury. Experimental Molecular Pathology 47: 193-201.
29. Jones JI, Gockerman A, Busby WH et al (1990) Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. Journal of Cellular Biology 121: 679-687.
30. Kelley KW (1989) Growth hormone, lymphocytes and macrophages. Biochemistry and Pharmacology 38: 705-713 (commentary).
31. Kirschner BS & Sutton MM (1986) Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology 91: 830-836.
32. Kirstein M, Aston C, Hintz R & Vlassara H (1992) Receptor specific induction of insulin-like growth factor-I (IGF-I) in human monocytes by advanced glycosylation and product-modified proteins. Journal of Clinical Investigation 90: 439-446.
33. Laburthe M, Rouyer-Fessard C & Gammeltoft S (1989) Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. American Journal of Physiology 254: G457-G462.
34. Lake FR, Noble PW, Henson PM & Riches DWH (1994) Functional switching of macrophage responses to tumor necrosis factor alpha (TNF) by interferons. Journal of Clinical Investigation 93: 1661-1669.
35. Lemmey ABL, Martin AA, Read LC et al (1991) IGF-I and the truncated analogue des-(1-3) IGF-I enhance growth in rat after gut resection. American Journal of Physiology 260: E213-E219.
36. Liu JP, Baker J, Perkins AS et al (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1r). Cell 75: 59-72.
37. Lund PK (1994) Insulin-like growth factors. In Dockray G & Walsh JH (eds) Gut Peptides: Biochemistry and Physiology, pp 587-613. New York: Raven Press.
38. Lund PK, Moats-Staats BM, Hynes MA et al (1986) Somatomedin-C/IGF-I and IGF-II mRNAs in rat fetal and adult tissues. Journal of Biological Chemistry 261: 14 539-14 544.
39. Matthes H, Herbst H, Schuppan D et al (1992) Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology 102: 431-442.
40. Mayer L (1992) Mucosal immune system in inflammatory bowel disease. In MacDermott RF & Stenson WF (eds) Inflammatory Bowel Disease, pp 53-76. New York: Elsevier Press.
41. McCusker RH, Camacho-Hubner C, Bayne ML et al (1990) Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effects of cell released IGF binding proteins (IGFBPs). Journal of Cell Physiology 144: 244-253.
42. Milenkovic L, Rettori V, Snyder GD et al (1989) Cachectin alters anterior pituitary hormone release by a direct action in vitro. Proceedings of the National Academy of Sciences of the USA 86: 2418-2422.
43. Mohapatra NK, Ulshen MH, Fuller CR et al (1995) Cell specific expression and regulation of insulin-like growth factor I (IGF-I) and IGF binding proteins (IGFBPs) during adaptive growth of small intestine. The 77th Annual Endocrine Society Meeting, Washington, DC, p. 96 abstract no. OR 37.5.
44. Mueller RV, Spencer EM, Sommer A et al (1991) The role of IGF-I and IGFBP-3 in wound healing. In Spencer E (ed.) Modern Concepts of Insulin-like Growth Factors, pp 185-192. New York: Elsevier Press.
45. Nagaoka J, Someya A, Iwabuchi K & Yamashita T (1991) Expression of insulin-like growth factor-IA and factor IB mRNA in human liver, hepatoma cells, macrophage-like cells, and fibroblasts. FEBS Letters 280: 79-83.
46. Nishimoto I, Murayama Y & Okamoto T (1991) Signal transduction mechanism of IGF-II/Man-6-P receptor. In Spencer E (ed.) Modern Concepts of Insulin-like Growth Factors, pp 517-528. New York: Elsevier Press.
47. Noble PW, Lake FR, Henson PM & Riches DWH (1993) Hyaluronate activation of CD44 induced insulin-like growth factor-1 expression by a tumor necrosis factor-a-dependent mechanism in murine macrophages. Journal of Clinical Investigation 91: 2368-2377.
48. Okayasu I, Hatakeyama S, Yamada M et al (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702.
49. Owen DA (1992) Pathology of inflammatory bowel disease. In MacDermott RP & Stenson WF (eds) Inflammatory Bowel Disease, pp 493-524. New York: Elsevier Press.
50. Park JHY Vanderhoof JA, Blackwood D & MacDonald RG (1990) Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line. Endocrinology 126: 2998-3005.
51. Park JHY, McCusker RH, Vanderhoof JA et al (1992) Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation. Endocrinology 131: 1359-1368.
52. Rappolee DA, Mark D, Banda MJ & Werb Z (1988) Wound macrophages express TGF-α and other growth factors in vivo: analysis by mRNA phenotyping. Science 241: 708-712.
53. Read LC, Lemmey AB, Howarth GS et al (1991) The gastrointestinal tract is one of the most responsive target tissues for IGF-I and its potential analogs. In Spencer E (ed.) Modern Concepts of Insulin-like Growth Factors, pp 225-231. New York: Elsevier Press.
54. Rechler MM (1993) Insulin-like growth factor binding proteins. Vitamins and Hormones. 47: 1-114.
55. Rom WM, Basset P, Fells GA et al (1988) Alveolar macrophages release an insulin-like growth factor I-type molecule. Journal of Clinical Investigation 82: 1685-1693.
56. Sappino AP, Schurch W & Gabbiani G (1990) Biology of disease: differentiation repertoire of fibro-blastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Laboratory Investigation 63(2): 144-158.
57. Sartor BF (1992) Animal models of intestinal inflammation: relevance to inflammatory bowel disease. In MacDermott RP & Stenson WF (eds) Inflammatory Bowel Disease, pp 493-524. New York: Elsevier Press.
58. Sartor BF (1994) Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106: 533-539.
59. Sartor RB, Cromartie WJ, Powell DW & Schwab JH (1985) Granulomatous enterocolitis induced by purified bacterial wall fragments. Gastroenterology 89: 587-595.
60. Simmons JG, Van Wyk JJ, Hoyt EC & Lund PK (1993) Multiple transcription sites in the rat IGF-I gene give rise to IGF-I mRNAs that encode different IGF-I precursors in cell-free systems. Growth Factors 9: 205-221.
61. Simmons JG, Hoyt EC, Westwick JK et al (1995) Insulin-like growth factor-I (IGF-I) and epidermal growth factor (EGF) interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells. Molecular Endocrinology 9: 1157-1165.
62. Stallmach A, Schuppan D, Riese HH et al (1992) Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 102: 1920-1929.
63. Taylor WR & Alexander RW (1993) Autocrine control of wound repair by insulin-like growth factor I in cultured endothelial cells. American Journal of Physiology 265: C810-C805.
64. Termanini B, Nardi RV, Finan TM et al (1990) Insulin-like growth factor I receptors in rabbit gastro-intestinal tract. Gastroenterology 98: 703-707.
65. Tyler JA (1989) Insulin-like growth factor I can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Journal of Biochemistry 260: 543-548.
66. Ulshen MH, Dowling RH, Fuller CR et al (1993) Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology 104: 973-980.
67. Underwood LE (1992) Therapeutic applications of human growth hormone. In Trends in Biotechnology, vol. 1(4). Philadelphia College of Pharmacy and Science: Office of Professional Programs.
68. Underwood LE (1994) Growth hormone treatment, acromegaly, and relationship to cancer and leukemia. In Bercu BB & Walker RF (eds) Growth Hormone II: Basic and Clinical Aspects, pp 259-268. New York: Springer Verlag.
69. Vanderhoof JA, Clark R, McCusker RH et al (1992) Effects of IGF-I and des (1-3) IGF-I on mucosal adaptation after jejunoileal resection in rats. Gastroenterology 102: 1949-1956.
70. Wahl SM (1991) Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. Journal of Clinical Immunology 12(2): 61-74.
71. Ward HC, Halliday D & Sim JW (1987) Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Annals of Surgery 206: 56-61.
72. Winesett DE, Ulshen MH, Hoyt EC et al (1995) Regulation and localization of the insulin-like growth factor system in small bowel during altered nutrient status. American Journal of Physiology G631-G640.
73. Yamamoto H & Murphy LJ (1994) Generation of des-(1-3) insulin-like growth factor-I in serum by an acid protease. Endocrinology 135(6): 2432-2439.
74. Zhee JM, Mohapatra N, Lund PK et al (1995) Differential expression and localization of IGF-I and IGF binding protein mRNA in inflamed rat colon. Gastroenterology 108(4): A948.
75. Ziegler RT, Young LS, Manson JM & Wilmore DW (1988) Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Annals of Surgery 208: 6-16.
76. Zimmermann EM, McNaughton K, Sartor RB & Lund PK (1993a) IGF-I is overexpressed in cells with a smooth muscle phenotype in peptidoglycan-polysaccharide induced chronic enterocolitis in the rat. Gastroenterology 104(4): A808 (abstract).
77. Zimmermann E, Sartor B, McCall RD et al (1993b) IGF-I and IG-Iβ in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology 105: 399-409.